Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine

Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine

February 6, 2026 · 13 min · Episode 60

About this episode

Dr. Matthew Sloan discusses the feasibility of delivering symptom-triggered alcohol withdrawal management over telemedicine.

In this episode of Beyond The Abstract, Dr. Matthew Sloan sits down to discuss findings from his recent article Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine featured in the November/December issue of the Journal of Addiction Medicine. Join us as Dr. Sloan shares insights into his study investigating the feasibility of delivering symptom-triggered alcohol withdrawal management over telemedicine. Dr. Matthew Sloan is a clinician scientist at the Centre for Addiction and Mental Health in Toronto, Ontario, Canada. He specializes in the treatment of substance use disorders and their psychiatric comorbidities. He completed medical school and psychiatry residency at McGill University followed by a postdoctoral fellowship in human psychopharmacology at the National Institutes of Health and an addiction psychiatry fellowship at Yale University. Dr. Sloan's primary research interests are developing innovative new treatments for substance use disorders and exploring determinants of psychopharmacological response to drugs of misuse. He has obtained competitive research funding from the Canadian Institutes of Health Research, Health Canada, and the Centre for…

More episodes of Addiction Medicine: Beyond the Abstract

Explore listener stats, chart rankings, contacts and more on the Addiction Medicine: Beyond the Abstract podcast page.